EyePoint Pharmaceuticals reports mixed results for DURAVYU in Phase 2 diabetic retinopathy trial
EyePoint Pharmaceuticals, Inc., committed to innovative therapeutics for serious retinal diseases, today disclosed the top-line results of the Phase 2 PAVIA clinical trial for DURAVYU ... Read More
Dr. Reddy’s Laboratories launches Versavo in UK, marking a milestone in cancer treatment
Dr. Reddy’s Laboratories Ltd., a leading global pharmaceutical company, has made significant strides in cancer treatment with the introduction of Versavo (bevacizumab) in the United ... Read More